About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DaVita HealthCare Partner (NY:DVA)

148.83 -1.15 (-0.77%)

Official Closing Price Updated: 4:00 PM EDT, Mar 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

3 No-Brainer Warren Buffett Stocks to Buy Right Now ↗

February 02, 2025

Via The Motley Fool

The Best Warren Buffett Stocks to Buy With $250 Right Now ↗

December 22, 2024

Via The Motley Fool

DaVita Stock Sees Improved Relative Strength Rating ↗

December 20, 2024

DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72.

Via Investor's Business Daily

The Best Warren Buffett Stocks to Buy With $1,000 Right Now ↗

November 25, 2024

Here are three of Warren Buffett's highest-conviction stocks.

Via The Motley Fool

Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul ↗

November 17, 2024

Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates.

Via Benzinga

What Analysts Are Saying About DaVita Stock ↗

October 07, 2024

Via Benzinga

Key Takeaways From DaVita Analyst Ratings ↗

August 08, 2024

Via Benzinga

Golden Years For M&A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates ↗

November 14, 2024

GOP control of Congress under Trump could lead to a surge in M&A activity, especially in banks and biotech. Factors like equity market returns and rate cuts could fuel deals, with small-cap targets and...

Via Benzinga

Topics Government

Why DaVita Stock Withered on Wednesday ↗

October 30, 2024

The company's profitability is going in the wrong direction for many investors.

Via The Motley Fool

Two Warren Buffett Stocks Get Pounded, With Apple Earnings Due ↗

October 30, 2024

This week marks a firehose of earnings from several top Buffett holdings.

Via Investor's Business Daily

DaVita (DVA) Q3 2024 Earnings Call Transcript ↗

October 29, 2024

DVA earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 29, 2024

Via Benzinga

6 Analysts Assess DaVita: What You Need To Know ↗

May 06, 2024

Via Benzinga

3 Buy Rated Stocks Cruising At 52 Week Highs ↗

October 02, 2024

Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions are rolling in. Let’s take a closer look at what’s been driving the bullish...

Via Talk Markets

AdaptHealth Stock Earns RS Rating Upgrade ↗

September 17, 2024

AdaptHealth stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 70 to 81.

Via Investor's Business Daily

3 Red Hot Stocks Flashing Buy Signals: DaVita, Intuitive Surgical, SharkNinja ↗

September 14, 2024

Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions come rolling in. That’s been precisely the case for Intuitive Surgical,...

Via Talk Markets

Bull Of The Day: Davita - Friday, September 6 ↗

September 06, 2024

Known to be the most volatile month for stocks, September is when many investors rebalance their portfolios to include less risky assets such as equities that provide exposure to essential healthcare...

Via Talk Markets

Top Medical Stocks To Hedge Against The September Effect ↗

September 04, 2024

While the Fed will likely cut interest rates in the coming weeks, September has historically been the most challenging month for stocks. Here are three top medical stocks to hedge against the September...

Via Talk Markets

Topics Economy

Nvidia is Down 21%. Here Are 3 Better Stocks to Buy for the Rest of 2024 ↗

August 13, 2024

The AI chipmaker has enjoyed a tremendous run-up, but its sky-high valuation means there are better stocks to buy than Nvidia.

Via InvestorPlace

Topics Artificial Intelligence

DaVita (DVA) Q2 2024 Earnings Call Transcript ↗

August 06, 2024

DVA earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

DVA stock results show that DaVita beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Financial Crime Weekly: DaVita Agrees To Pay $34.5M For Kickbacks, Hospice Provider Doles Out $19.4M For False Claims ↗

July 19, 2024

DaVita Inc., a kidney dialysis provider, will pay $34.5 million for allegedly paying kickbacks to competitors and doctors for patient referrals.

Via Benzinga

2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid ↗

June 15, 2024

As the late Meatloaf once sang, "Two out of three ain't bad."

Via The Motley Fool

Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway ↗

June 11, 2024

You can't go wrong by following in the Oracle's footsteps and buying these cheap Buffett stocks before the market catches on.

Via InvestorPlace

These Warren Buffett Stocks Are Trouncing the S&P 500 so Far This Year. Are They Still Buys? ↗

June 07, 2024

Buffett no doubt likes what he's seeing with these high-flying stocks.

Via The Motley Fool

Topics Stocks

Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers ↗

May 17, 2024

Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and...

Via Benzinga

Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Reverses, Nearly Triggering A Sell Signal ↗

May 03, 2024

Tandem Diabetes stock surged above a profit-taking zone on Friday, but DaVita reversed course and tumbled at the open.

Via Investor's Business Daily

The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy? ↗

May 03, 2024

Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses.

Via InvestorPlace

DaVita (DVA) Q1 2024 Earnings Call Transcript ↗

May 02, 2024

DVA earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q1 2024 ↗

May 02, 2024

DVA stock results show that DaVita beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

DaVita HealthCare Partner (NY:DVA)

All News about DaVita HealthCare Partner

Sections

Services

Contact Information

Follow Us